• bronchitis
• bronchitis - COPD exacerbation
• comm-acq pneumonia - Legionella
• comm-acq pneumonia - S. aureus (non-MRSA)
• community-acquired pneumonia - anaerobes
• community-acquired pneumonia - Chlamydophila
• community-acquired pneumonia - H. influenzae
• community-acquired pneumonia - Klebsiella pneumoniae
• community-acquired pneumonia - Mycoplasma
• community-acquired pneumonia - pneumococcus
• community-acquired pneumonia - Pseudomonas aeruginosa
• community-acquired pneumonia - Q fever
• COVID-19
• LRTI 2.1 Hospital-acquired pneumonia (HAP)
• LWI 1.1 Community-acquired pneumonia (CAP) - unknown pathogen - mild (AMBU 0-1)
• LWI 1.2 Community-acquired pneumonia (CAP) - unknown pathogen - moderately severe (AMBU-65 2)
• LWI 1.3 Community-acquired pneumonia (CAP) - unknown pathogen - severe (AMBU-65 3-5) NO ICU admission
• LWI 1.4 Community-acquired pneumonia (CAP) - unknown pathogen - severe (AMBU-65 3-5) WITH ICU admission
• LWI 3.6 Pneumonia - (bacterial) Bordetella pertussis (whooping cough)
• LWI 7.1 Cystic fibrosis (CF)
• LWI 8.2 Lung abscess
• pertussis
• pleural empyema
• Respiratory Syncytial Virus (RSV)
• Respiratory tract infection (RTI) 5.2 Pneumonia - (fungal) Aspergillus
• RTI 5.1 Pneumonia - (fungal) Pneumocystis jirovecii (PJP)